Ulisse Biomed S.p.A.

BIT:UBM Stock Report

Market Cap: €19.2m

Ulisse Biomed Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Nicola Basile

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureno data
Board average tenureless than a year

Recent management updates

Recent updates

A Look At The Fair Value Of Ulisse Biomed S.p.A. (BIT:UBM)

Jun 24
A Look At The Fair Value Of Ulisse Biomed S.p.A. (BIT:UBM)

We Think Ulisse Biomed (BIT:UBM) Can Afford To Drive Business Growth

Feb 17
We Think Ulisse Biomed (BIT:UBM) Can Afford To Drive Business Growth

CEO

Nicola Basile (45 yo)

less than a year

Tenure

Mr. Nicola Basile is CEO & Director of Ulisse Biomed S.p.A. from March 2024.

Board Members

NamePositionTenureCompensationOwnership
Nicola Basile
CEO & Directorless than a yearno datano data
Bruna Marini
Co-founderno datano datano data
Carlo Montenovesi
Executive Directorless than a yearno datano data
Robert Gallo
Member of Scientific Boardno datano datano data
Gordon Whiteley
Member of Scientific Boardno datano datano data
Alberto Camilotti
Chairman of the Board of Statutory Auditorsno datano datano data
Joseph Kates
Chairman of Scientific Boardno datano datano data
Lawrence Banks
Member of Scientific Boardno datano datano data
Davide Zella
Member of Scientific Boardno datano datano data
Clara Carbone
Standing Auditorless than a yearno datano data
Stefano Priore
Non-Executive Chairmanless than a yearno datano data
Aurora Agostini
Independent Directorless than a yearno datano data

0.7yrs

Average Tenure

53yo

Average Age

Experienced Board: UBM's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.